The angiotensin II type 1 receptor antagonist Losartan binds and activates bradykinin B2 receptor signaling

Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator–Activated Receptor-γ Activity

Michael Schupp, Jürgen Janke, R. Clasen et al. · Circulation · 2004 · 710 citations

Medicine, Endocrinology, Pharmacology +17

Myocardial Protection by Preconditioning of Heart With Losartan, an Angiotensin II Type 1-Receptor Blocker : Implication of Bradykinin-Dependent and Bradykinin-Independent Mechanisms

Masa H. Sato, Richard M. Engelman, Hajime Otani et al. · Circulation · 2000 · 85 citations

Medicine, Cardiology, Pharmacology +13

The Antiarrhythmic Peptide Analog ZP123 Prevents Atrial Conduction Slowing During Metabolic Stress

Ketil Haugan, Kristine Boisen Olsen, Line Hartvig et al. · Journal of Cardiovascular Electrophysiology · 2005 · 71 citations

Medicine, Cardiology, Pharmacology +17

Effects of peptide and nonpeptide antagonists of bradykinin B2 receptors on the venoconstrictor action of bradykinin.

François Marceau, Luc Lévesque, G. Drapeau et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 71 citations

Medicine, Pharmacology, Clinical Pharmacology +8

Control of Conformational Equilibria in the Human B2 Bradykinin Receptor

Jacky Marie, Eric Richard, Didier Pruneau et al. · Journal of Biological Chemistry · 2001 · 60 citations · Full text

Medicine, Biochemistry, Pharmacology +17